Skip to content

TARGET-Metabolic Effects

The Augmented Versus Routine Approach to Giving Energy Trial Metabolic Effects Sub-study (TARGET-ME)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03793244
Acronym
TARGET-ME
Enrollment
42
Registered
2019-01-04
Start date
2017-07-01
Completion date
2018-08-01
Last updated
2019-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Enteral Nutrition

Brief summary

The estimation of calorie needs during routine practice in critically ill patients is highly variable and the thermogenic effect of continuous delivery of enteral nutrition (EN) on overall calorie utilisation in critically ill adults is unknown. The TARGET-ME study is a substudy of the TARGET trial (NCT02306746). The TARGET trial provides the perfect opportunity to measure calorie utilisation via indirect calorimetry (IC) and ventilator-derived carbon dioxide production (VCO2) to compare measured calorie utilisation to estimation methods, determine the potential thermic effect of EN solutions with different energy concentrations and investigate any associations with outcome.

Interventions

Enteral nutrition

Sponsors

The Canberra Hospital
CollaboratorOTHER
Royal Adelaide Hospital
CollaboratorOTHER
Auckland City Hospital
CollaboratorOTHER_GOV
Melbourne Health
CollaboratorOTHER
Australian and New Zealand Intensive Care Research Centre
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients must first meet the inclusion and none of the

Exclusion criteria

for the TARGET main trail (NCT02306746). The following additional criteria applies for this study when indirect calorimetry is being used: * Within 48 hours of randomisation to TARGET (first measurement only) * Fi02 \< 50% for the past 1 hour * Positive end expiratory pressure (PEEP) \< 12 mmHg for the past 1 hour * The IC test can be conducted within 48 hours of randomisation to TARGET * The patient is not considered agitated using the usual site assessment * There is a clinician available to complete the test

Design outcomes

Primary

MeasureTime frameDescription
Calorie difference in kcalUp to day 28Difference in mean calorie delivery and mean measured calorie utilisation over the study period (expressed as a percentage of measured requirements received) in each study group

Secondary

MeasureTime frameDescription
Calorie difference in kcal in the whole study cohortUp to day 28Calorie difference in kcal between mean calorie delivery and mean measured calorie utilisation over the study period (expressed as a percentage of measured requirements received) in the whole study cohort

Other

MeasureTime frameDescription
Calorie difference in kcalUp to day 28Calorie difference in kcal between mean measured calorie utilisation and mean calorie requirements predicted by the estimation method used in TARGET and in routine clinical practice
Energy balanceUp to day 28Energy balance in both the intervention and standard care groups (with measured calorie utilisation as the reference) up until 4 weeks post randomisation
Degree of diet induced thermogenesisUp to day 28measured as the difference between mean measured calorie utilisation in kcal between the two intervention groups
Correlation of energy expenditure (EE) assessed by IC and VCO2 compared to predictive equations estimates of EEUp to day 28Correlation (bias, precision, accuracy rates) of EE assessed by IC and VCO2 compared to predictive equations estimates of EE

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026